Blog

Publish Date
C4IP Coalition Updates: November 2025

November Highlights: The Upcoming Review of the USMCA This fall marked the beginning of the first scheduled Joint Review process for the...

This Month in IP: November 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From gardening...

Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

Inventor Spotlight: Ronald Rivest, Adi Shamir, and Leonard Adleman

C4IP is honoring Ronald Rivest (born 1947), Adi Shamir (b. 1952), and Leonard Adleman (b. 1945), whose invention of RSA cryptography forms...

Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

‘Tis the Season — of Counterfeits?

Counterfeiting is a multi-billion-dollar enterprise that puts consumers at serious risk. Poorly-made laptop batteries can overheat. Knock-off cosmetics may contain toxic chemicals....

This Month in IP: October 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From firefighting...

C4IP Coalition Updates: October 2025

October Highlights: C4IP Advocates for the Patent Eligibility Restoration Act On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a...

Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Highlights from the October 8 PERA Hearing

On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the Patent Eligibility Restoration Act (PERA) to examine...

Inventor Spotlight: Malcom McLean

C4IP is honoring Malcom McLean (1913-2001), whose invention of containerized shipping revolutionized global trade. Born into a farming family in North Carolina,...

Blog:

Blog:

C4IP Coalition Updates: January 2025,

02/06/2025

Blog:

Blog:

This Month in IP: January 2025,

02/06/2025

Op-Eds:

Blog, Op-Eds:

Encouraging Human Creativity in the AI-Powered Future,

01/29/2025

Blog:

Blog:

Debunking Patent Disinformation: Insights from the USPTO’s Drug Patent and Exclusivity Study,

01/28/2025

Op-Eds:

Blog, Op-Eds:

A Reality Check for Patent Quality Critics,

01/22/2025

Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act,

01/09/2025

Blog:

Blog:

Inventor Spotlight: William Kroll,

01/03/2025

Blog:

Blog:

C4IP Coalition Updates: December 2024,

12/20/2024

Blog:

Blog:

This Month in IP: December 2024,

12/20/2024

Blog:

Blog:

Inventor Spotlight: Philo T. Farnsworth,

12/17/2024

Blog:

Blog, Fact Checks:

Fact Check: Claims that Researchers Aren’t Reporting Federal Funding Don’t Hold Up to Scrutiny,

12/12/2024

Blog:

Blog:

C4IP Coalition Updates: November 2024,

12/05/2024

Scroll to Top